-
EP4161582
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4161582
| EP4161582 - ANTIBODY-DRUG CONJUGATES CONTAINING AN ANTI-MESOTHELIN ANTIBODY AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 10.03.2023 Database last updated on 14.11.2024 | |
| Former | The international publication has been made Status updated on 10.12.2021 | Most recent event Tooltip | 01.11.2024 | Amendment by applicant | Applicant(s) | For all designated states Development Center for Biotechnology No. 101 Lane 169 Kangning St. Xizhi District New Taipei City 221 / TW | [2023/15] | Inventor(s) | 01 /
CHUANG, Shih-Hsien Taipei City, 115 / TW | 02 /
SUN, Wei-Ting Taipei City, 115 / TW | 03 /
LAILEE, Ying-Shuan Taipei City, 115 / TW | 04 /
LAI, Chun-Liang Taipei City, 115 / TW | 05 /
LIN, Wun-Huei Taipei City, 115 / TW | 06 /
WEI, Win-Yin Taipei City, 115 / TW | 07 /
TSAI, Shih-Chong Taipei City, 115 / TW | 08 /
YU, Cheng-Chou Taipei City, 115 / TW | 09 /
HUANG, Chao-Yang Taipei City, 115 / TW | [2023/15] | Representative(s) | 2K Patentanwälte Blasberg Kewitz & Reichel Partnerschaft mbB Schumannstrasse 27 60325 Frankfurt am Main / DE | [2023/15] | Application number, filing date | 21816712.0 | 04.06.2021 | [2023/15] | WO2021US35972 | Priority number, date | US202063035175P | 05.06.2020 Original published format: US 202063035175 P | [2023/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2021248048 | Date: | 09.12.2021 | Language: | EN | [2021/49] | Type: | A2 Application without search report | No.: | EP4161582 | Date: | 12.04.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.12.2021 takes the place of the publication of the European patent application. | [2023/15] | Search report(s) | International search report - published on: | US | 27.01.2022 | (Supplementary) European search report - dispatched on: | EP | 15.04.2024 | Classification | IPC: | A61K47/68, C07K16/32, C07K16/46, A61P35/00 | [2024/20] | CPC: |
A61P35/00 (EP,KR,US);
A61K47/6851 (EP,KR,US);
A61K47/545 (US);
A61K47/6803 (KR);
A61K47/68031 (EP,US);
A61K47/68033 (EP,US);
A61K47/68037 (EP,US);
A61K47/6817 (US);
A61K47/6889 (EP,KR,US);
|
| Former IPC [2023/15] | A61K47/68, C07K16/32, C07K16/46 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/15] | Title | German: | ANTIKÖRPER-WIRKSTOFF-KONJUGATE MIT EINEM ANTI-MESOTHELIN-ANTIKÖRPER UND VERWENDUNGEN DAVON | [2023/15] | English: | ANTIBODY-DRUG CONJUGATES CONTAINING AN ANTI-MESOTHELIN ANTIBODY AND USES THEREOF | [2023/15] | French: | CONJUGUÉS ANTICORPS-MÉDICAMENT CONTENANT UN ANTICORPS ANTI-MÉSOTHÉLINE ET LEURS UTILISATIONS | [2023/15] | Entry into regional phase | 13.12.2022 | National basic fee paid | 13.12.2022 | Search fee paid | 13.12.2022 | Designation fee(s) paid | 13.12.2022 | Examination fee paid | Examination procedure | 13.12.2022 | Examination requested [2023/15] | 30.10.2024 | Amendment by applicant (claims and/or description) | 30.10.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 30.06.2023 | Renewal fee patent year 03 | 02.04.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2017137457 (SYNAFFIX BV [NL]); | [I]WO2018146199 (ADC THERAPEUTICS SA [CH], et al); | [A]US2020087697 (TSAI SHIH-CHONG [TW], et al); | International search | [Y]US2015031624 (FELDMAN STEVEN A [US], et al); | [A]WO2016201240 (SIAMAB THERAPEUTICS INC [US], et al); | [A]US2019194686 (LU HSIN-LIN [TW], et al); | [Y]US2020087697 (TSAI SHIH-CHONG [TW], et al) |